Physician

Fayssal El-Jabali, D.O.

According to 2025 Medicare claims, Fayssal El-Jabali, D.O. (NPI: 1629199096) practices ophthalmology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is EYE ASSOCIATES OF MANATEE, LLP (NPI: 1366483851; TIN: 650105559) and primary practice location at 34222-3532. El-Jabali is affiliated with the Pearl Primary Care Network, LLC (ACO ID: D0242), participating under the REACH model.

El-Jabali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 478 traditional Medicare patients, billed 13,586 HCPCS/CPT codes, and received $2,330,232 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 446 prescription claims across 106 beneficiaries totaling $627,438 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 28 records totaling $1,995. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $2,013,911 and ending at $2,330,232. Concurrently, Part D prescription costs have risen steadily, from $7,519 to $627,438. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	499	9,185	$2,013,911
2016	939	6,904	$605,340
2017	1,058	11,111	$901,366
2018	963	10,446	$994,960
2019	380	2,217	$291,095
2020	406	4,229	$792,066
2021	404	5,417	$1,191,261
2022	413	6,028	$1,407,554
2023	338	5,927	$1,475,754
2024	478	13,586	$2,330,232

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	55	167	$7,519
2016	61	137	$11,053
2017	79	309	$54,857
2018	79	249	$56,424
2019	79	220	$29,406
2020	148	540	$174,638
2021	156	479	$121,999
2022	187	716	$1,006,888
2023	73	260	$209,227
2024	106	446	$627,438

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	123	1,950	$641
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	76	76	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	400	857	$95
67028	Injection of drug into eye	189	1,232	$93
92134	Imaging of retina	464	1,497	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eylea	Aflibercept	168	4,704	$480,652
Izervay	Avacincaptad Pegol Sodium/Pf	17	476	$60,900
Prednisolone Acetate	Prednisolone Acetate	78	2,006	$3,048
Atropine Sulfate	Atropine Sulfate	25	443	$858
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	840	$377

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$1,995	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Fayssal El-Jabali, D.O.?

Tedicare shows public-source Medicare data for Fayssal El-Jabali, D.O. (NPI 1629199096), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fayssal El-Jabali, D.O. have ACO affiliation data?

Fayssal El-Jabali, D.O. is shown with ACO affiliation data for Pearl Primary Care Network, LLC (REACH, ACO ID D0242).

What billing organization is linked to Fayssal El-Jabali, D.O.?

Fayssal El-Jabali, D.O. is linked to EYE ASSOCIATES OF MANATEE, LLP (billing NPI 1366483851) in the available physician profile data.

Does Fayssal El-Jabali, D.O. have Open Payments data?

Fayssal El-Jabali, D.O. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.